Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PFIZER INCPFE · Entity 2863 | Executive Vice President | March 06, 2018 | March 07, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PFIZER INC
Report date March 06, 2018 · Filed March 07, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 57,328 |
Ending reported balance
After 2018-03-06 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2018-03-06 · Sale · Disposed 316 · Balance 99,405 Row 2 · 2018-03-06 · Sale · Disposed 330 · Balance 99,075 Row 3 · 2018-03-06 · Sale · Disposed 493 · Balance 98,582 Row 4 · 2018-03-06 · Sale · Disposed 10,715 · Balance 87,867 Row 5 · 2018-03-06 · Sale · Disposed 30,539 · Balance 57,328 |
| Common StockSEC Table I · non-derivative | IndirectBy Rule 16b-3 Plan | 11,414 |
Reported balance
Holding disclosure · report date 2018-03-06 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 11,414 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2018 Filed Mar 7, 2018 21:09 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 30,539 | $35.78 | $1,092,685.42 |
DisclosureSEC source: 0001225208-18-005645 · doc4.xml · nonDerivative · entry 5 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,328 Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 21:09 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 10,715 | $35.70 | $382,525.50 |
DisclosureSEC source: 0001225208-18-005645 · doc4.xml · nonDerivative · entry 4 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,867 Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 21:09 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 493 | $35.79 | $17,644.47 |
DisclosureSEC source: 0001225208-18-005645 · doc4.xml · nonDerivative · entry 3 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,582 Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 21:09 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 330 | $35.80 | $11,814.00 |
DisclosureSEC source: 0001225208-18-005645 · doc4.xml · nonDerivative · entry 2 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,075 Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 21:09 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 316 | $35.81 | $11,315.96 |
DisclosureSEC source: 0001225208-18-005645 · doc4.xml · nonDerivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,405 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 101,872 | $0.00 Strike: $27.37 | $0.00 |
DisclosureSEC source: 0001225208-18-005098 · doc4.xml · derivative · entry 9 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 101,872 shares Expires 2018-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 61,836 | $35.70 | $2,207,545.20 |
DisclosureSEC source: 0001225208-18-005098 · doc4.xml · nonDerivative · entry 7 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,721 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 19,606 | $36.31 | $711,893.86 |
DisclosureSEC source: 0001225208-18-005098 · doc4.xml · nonDerivative · entry 6 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,557 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations and payment of exercise price in connection with the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 17,079 | $36.83 | $629,019.57 |
DisclosureSEC source: 0001225208-18-005098 · doc4.xml · nonDerivative · entry 5 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,163 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 5,400 | $36.82 | $198,828.00 |
DisclosureSEC source: 0001225208-18-005098 · doc4.xml · nonDerivative · entry 4 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,242 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 3,200 | $36.85 | $117,920.00 |
DisclosureSEC source: 0001225208-18-005098 · doc4.xml · nonDerivative · entry 3 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,642 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 1,100 | $36.84 | $40,524.00 |
DisclosureSEC source: 0001225208-18-005098 · doc4.xml · nonDerivative · entry 2 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,842 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 101,872 | $27.37 | $2,788,236.64 |
DisclosureSEC source: 0001225208-18-005098 · doc4.xml · nonDerivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 23:05 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 21,078 | $37.09 | $781,783.02 |
DisclosureSEC source: 0001225208-18-004661 · doc4.xml · nonDerivative · entry 2 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,070 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 23:05 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 43,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-004661 · doc4.xml · nonDerivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,148 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 24, 2018 Filed Feb 28, 2018 00:38 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 65,280 | $0.00 Strike: $18.90 | $0.00 |
DisclosureSEC source: 0001225208-18-004461 · doc4.xml · derivative · entry 5 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 65,280 shares Expires 2018-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2018 Filed Feb 28, 2018 00:38 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 20,829 | $35.98 | $749,427.42 |
DisclosureSEC source: 0001225208-18-004461 · doc4.xml · nonDerivative · entry 3 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,106 F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 24, 2018 Filed Feb 28, 2018 00:38 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 17,674 | $36.26 | $640,859.24 |
DisclosureSEC source: 0001225208-18-004461 · doc4.xml · nonDerivative · entry 2 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,935 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. F3 · price: Price is the closing price of Pfizer common stock on February 23, 2018 Read SEC document |
| February 24, 2018 Filed Feb 28, 2018 00:38 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 65,280 | $18.90 | $1,233,792.00 |
DisclosureSEC source: 0001225208-18-004461 · doc4.xml · nonDerivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,609 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 22, 2018 Filed Feb 23, 2018 20:47 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 75,495 | $0.00 Strike: $35.74 | $0.00 |
DisclosureSEC source: 0001225208-18-003967 · doc4.xml · derivative · entry 2 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,495 Underlying: Common Stock · 75,495 shares Expires 2025-02-22 F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 22, 2018 Filed Feb 23, 2018 20:47 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 90,303 | $0.00 Strike: $35.74 | $0.00 |
DisclosureSEC source: 0001225208-18-003967 · doc4.xml · derivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,303 Underlying: Common Stock · 90,303 shares Expires 2023-02-22 F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 22:40 UTC | PFIZER INC PFE · Entity 2863 | OtherPhantom Stock Units SSP · Derivative | 14,140 | $35.36 | $499,990.40 |
DisclosureSEC source: 0001225208-17-015101 · doc4.xml · derivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,131 Underlying: Common Stock · 14,140 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F3 · derivative.underlying_shares: This transaction constitutes an intra-plan transfer involving the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan. Read SEC document |
| March 09, 2017 Filed Mar 10, 2017 20:59 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 36,000 | $34.07 | $1,226,520.00 |
DisclosureSEC source: 0001225208-17-006071 · doc4.xml · nonDerivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,329 Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:10 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 8,621 | $34.28 | $295,527.88 |
DisclosureSEC source: 0001225208-17-005103 · doc4.xml · nonDerivative · entry 3 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,329 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:10 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 8,319 | $34.28 | $285,175.32 |
DisclosureSEC source: 0001225208-17-005103 · doc4.xml · nonDerivative · entry 2 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,950 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:10 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 16,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-005103 · doc4.xml · nonDerivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,269 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 23:24 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 84,232 | $0.00 Strike: $34.06 | $0.00 |
DisclosureSEC source: 0001225208-17-004773 · doc4.xml · derivative · entry 4 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,232 Underlying: Common Stock · 84,232 shares Expires 2024-02-23 F3 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F3 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 23:24 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 101,461 | $0.00 Strike: $34.06 | $0.00 |
DisclosureSEC source: 0001225208-17-004773 · doc4.xml · derivative · entry 3 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,461 Underlying: Common Stock · 101,461 shares Expires 2022-02-23 F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 23:24 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 22,837 | $34.06 | $777,828.22 |
DisclosureSEC source: 0001225208-17-004773 · doc4.xml · nonDerivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,553 F1 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| November 03, 2016 Filed Nov 7, 2016 22:50 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 109,223 | $0.00 Strike: $21.03 | $0.00 |
DisclosureSEC source: 0001225208-16-041272 · doc4.xml · derivative · entry 3 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 109,223 shares Expires 2017-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2016 Filed Nov 7, 2016 22:50 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 53,918 | $21.03 | $1,133,895.54 |
DisclosureSEC source: 0001225208-16-041272 · doc4.xml · nonDerivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,033 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in our common stock price (20 trading day average ending on the exercise date (Election Price)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the fifth anniversary of grant. Read SEC document |
| June 09, 2016 Filed Jun 13, 2016 22:25 UTC | PFIZER INC PFE · Entity 2863 | OtherPhantom Stock Units SSP · Derivative | 11,328 | $35.31 | $399,991.68 |
DisclosureSEC source: 0001225208-16-034955 · doc4.xml · derivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,987 Underlying: Common Stock · 11,328 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: This transaction constitutes an intra-plan transfer involving the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan. F3 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F3 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 09, 2016 Filed May 11, 2016 20:35 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 28,300 | $33.84 | $957,672.00 |
DisclosureSEC source: 0001225208-16-033154 · doc4.xml · nonDerivative · entry 2 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,828 Read SEC document |
| May 09, 2016 Filed May 11, 2016 20:35 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 1,300 | $33.83 | $43,979.00 |
DisclosureSEC source: 0001225208-16-033154 · doc4.xml · nonDerivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,128 Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 9,462 | $30.23 | $286,036.26 |
DisclosureSEC source: 0001225208-16-028808 · doc4.xml · nonDerivative · entry 3 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,428 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 4,912 | $30.23 | $148,489.76 |
DisclosureSEC source: 0001225208-16-028808 · doc4.xml · nonDerivative · entry 2 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,890 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 9,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-028808 · doc4.xml · nonDerivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,802 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 25, 2016 Filed Feb 26, 2016 20:05 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 70,300 | $0.00 Strike: $30.59 | $0.00 |
DisclosureSEC source: 0001225208-16-028379 · doc4.xml · derivative · entry 7 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,300 Underlying: Common Stock · 70,300 shares Expires 2023-02-25 F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 25, 2016 Filed Feb 26, 2016 20:05 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 78,664 | $0.00 Strike: $30.59 | $0.00 |
DisclosureSEC source: 0001225208-16-028379 · doc4.xml · derivative · entry 6 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,664 Underlying: Common Stock · 78,664 shares Expires 2021-02-25 F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 24, 2016 Filed Feb 26, 2016 20:05 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 78,855 | $0.00 Strike: $18.90 | $0.00 |
DisclosureSEC source: 0001225208-16-028379 · doc4.xml · derivative · entry 5 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 78,855 shares Expires 2016-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2016 Filed Feb 26, 2016 20:05 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 37,209 | $29.67 | $1,103,991.03 |
DisclosureSEC source: 0001225208-16-028379 · doc4.xml · nonDerivative · entry 3 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,279 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 24, 2016 Filed Feb 26, 2016 20:05 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 16,647 | $30.02 | $499,742.94 |
DisclosureSEC source: 0001225208-16-028379 · doc4.xml · nonDerivative · entry 2 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,488 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 24, 2016 Filed Feb 26, 2016 20:05 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 78,855 | $18.90 | $1,490,359.50 |
DisclosureSEC source: 0001225208-16-028379 · doc4.xml · nonDerivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,135 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| June 02, 2015 Filed Jun 3, 2015 14:09 UTC | PFIZER INC PFE · Entity 2863 | OtherCommon Stock | 2,156 | $34.49 | $74,360.44 |
DisclosureSEC source: 0001225208-15-013251 · doc4.xml · nonDerivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Rule 16b-3 Plan Disclosed balance after: 10,329 F1 · shares: This transaction constitutes an intra-plan transfer involving the Pfizer stock fund under the Company's Qualified Savings Plan. Read SEC document |
| May 29, 2015 Filed Jun 2, 2015 20:54 UTC | PFIZER INC PFE · Entity 2863 | OtherPhantom Stock Units SSP · Derivative | 33,278 | $34.75 | $1,156,410.50 |
DisclosureSEC source: 0001225208-15-013178 · doc4.xml · derivative · entry 3 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,972 Underlying: Common Stock · 33,278 shares Expires not disclosed F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F3 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F3 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F4 · derivative.underlying_shares: This transaction constitutes an intra-plan transfer involving the Pfizer stock unit fund under the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan. Read SEC document |
| May 29, 2015 Filed Jun 2, 2015 20:54 UTC | PFIZER INC PFE · Entity 2863 | OtherCommon Stock | 7,489 | $34.75 | $260,242.75 |
DisclosureSEC source: 0001225208-15-013178 · doc4.xml · nonDerivative · entry 2 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Rule 16b-3 Plan Disclosed balance after: 8,173 F1 · shares: This transaction constitutes an intra-plan transfer involving the Pfizer stock fund under the Company's Qualified Savings Plan. Read SEC document |
| May 29, 2015 Filed Jun 2, 2015 20:54 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 42,870 | $34.92 | $1,497,020.40 |
DisclosureSEC source: 0001225208-15-013178 · doc4.xml · nonDerivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,357 Read SEC document |
| February 26, 2015 Filed Feb 27, 2015 23:42 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 60,403 | $0.00 Strike: $34.59 | $0.00 |
DisclosureSEC source: 0001225208-15-006197 · doc4.xml · derivative · entry 9 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,403 Underlying: Common Stock · 60,403 shares Expires 2022-02-26 F8 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F8 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 26, 2015 Filed Feb 27, 2015 23:42 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 72,464 | $0.00 Strike: $34.59 | $0.00 |
DisclosureSEC source: 0001225208-15-006197 · doc4.xml · derivative · entry 8 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,464 Underlying: Common Stock · 72,464 shares Expires 2020-02-26 F7 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F7 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2015 Filed Feb 27, 2015 23:42 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 22,523 | $0.00 Strike: $17.69 | $0.00 |
DisclosureSEC source: 0001225208-15-006197 · doc4.xml · derivative · entry 7 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,523 shares Expires 2015-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.